These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

99 related articles for article (PubMed ID: 1363902)

  • 1. [Evaluation of treatments with beta-blockaders after myocardial infarction].
    Haïat R; Roussin I; Leroy G
    Arch Mal Coeur Vaiss; 1992 Nov; 85(11 Suppl):1697-702. PubMed ID: 1363902
    [TBL] [Abstract][Full Text] [Related]  

  • 2. [Secondary prophylaxis with beta blockers after myocardial infarction].
    Bosković D
    Srp Arh Celok Lek; 1992 Jun; 120 Suppl 4():25-34. PubMed ID: 18193807
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Beta-adrenergic blockers in patients with acute myocardial infarction.
    Furberg CD; Byington RP
    Cardiovasc Clin; 1989; 20(1):235-48. PubMed ID: 2565768
    [TBL] [Abstract][Full Text] [Related]  

  • 4. [Secondary prevention of myocardial infarct with anti-arrhythmia drugs and beta receptor blockaders].
    Mösslacher H
    Wien Med Wochenschr; 1984 Dec; 134(23-24):566-72. PubMed ID: 6152091
    [TBL] [Abstract][Full Text] [Related]  

  • 5. The role of beta-blockers in the treatment of patients after infarction.
    Pratt CM; Young JB; Roberts R
    Cardiol Clin; 1984 Feb; 2(1):13-20. PubMed ID: 6152718
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Secondary prevention after myocardial infarction: in favor of beta-blockers.
    Lévy S
    J Cardiovasc Pharmacol; 1990; 16 Suppl 6():S50-4. PubMed ID: 1707116
    [TBL] [Abstract][Full Text] [Related]  

  • 7. [Therapeutic measures following acute myocardial infarct: differential use of PTCA, surgery and drugs].
    Noll G; Kaufmann U; Wenzel RR; Lüscher TF
    Schweiz Med Wochenschr; 1996 Feb; 126(5):164-76. PubMed ID: 8685687
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Usefulness of beta blockers in high-risk patients after myocardial infarction in conjunction with captopril and/or valsartan (from the VALsartan In Acute Myocardial Infarction [VALIANT] trial).
    Califf RM; Lokhnygina Y; Velazquez EJ; McMurray JJ; Leimberger JD; Lewis EF; Diaz R; Murin J; Pfeffer MA
    Am J Cardiol; 2009 Jul; 104(2):151-7. PubMed ID: 19576338
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Beta-adrenoceptor blockade and myocardial infarction: when should treatment start and for how long should it continue?
    Baber NS; Lewis JA
    Circulation; 1983 Jun; 67(6 Pt 2):I71-7. PubMed ID: 6133647
    [TBL] [Abstract][Full Text] [Related]  

  • 10. [Beta blockade in acute myocardial infarction].
    Bosković D; Terzić B; Perunicić J; Zugić M; Beleslin BD
    Srp Arh Celok Lek; 1992 Jun; 120 Suppl 4():17-24. PubMed ID: 18196643
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Beta-blockade after myocardial infarction: practical implications of major clinical trials.
    Rehnqvist N; Olsson G
    J Cardiovasc Pharmacol; 1987; 10 Suppl 2():S10-4. PubMed ID: 2481157
    [TBL] [Abstract][Full Text] [Related]  

  • 12. [Use of beta-blockers in the acute phase of myocardial infarction].
    Marcillac-Desruennes M; Weber S; Degeorges M
    Ann Cardiol Angeiol (Paris); 1984 Dec; 33(8):519-23. PubMed ID: 6152138
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Myocardial infarction. Effects of beta-blockade.
    Hjalmarson A; Olsson G
    Circulation; 1991 Dec; 84(6 Suppl):VI101-7. PubMed ID: 1683604
    [TBL] [Abstract][Full Text] [Related]  

  • 14. [Beta blockers in arrhythmias].
    Fuhrer J
    Praxis (Bern 1994); 1995 Mar; 84(11):304-12. PubMed ID: 7724946
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Prevention of sudden cardiac death with beta blockers.
    Hjalmarson A
    Clin Cardiol; 1999 Oct; 22 Suppl 5():V11-5. PubMed ID: 10526698
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Rationale, design and organization of the Second Chinese Cardiac Study (CCS-2): a randomized trial of clopidogrel plus aspirin, and of metoprolol, among patients with suspected acute myocardial infarction. Second Chinese Cardiac Study (CCS-2) Collaborative Group.
    Second Chinese Cardiac Study (CCS-2) Collaborative Group
    J Cardiovasc Risk; 2000 Dec; 7(6):435-41. PubMed ID: 11189013
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Do results from major clinical trials indicate a change in management in the acute phase of myocardial infarction?
    Hjalmarson A
    J Cardiovasc Pharmacol; 1987; 10 Suppl 2():S2-8; discussion S9. PubMed ID: 2481164
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Primary and secondary prevention of myocardial infarction and strokes: an update of randomly allocated, controlled trials.
    Yusuf S; Lessem J; Jha P; Lonn E
    J Hypertens Suppl; 1993 Jun; 11(4):S61-73. PubMed ID: 8104243
    [TBL] [Abstract][Full Text] [Related]  

  • 19. The Beta-Blocker Pooling Project (BBPP): subgroup findings from randomized trials in post infarction patients. The Beta-Blocker Pooling Project Research Group.
    Eur Heart J; 1988 Jan; 9(1):8-16. PubMed ID: 2894312
    [TBL] [Abstract][Full Text] [Related]  

  • 20. [Secondary prevention of myocardial infarct with beta blockers].
    Vacheron A; Baubion N; Delage F
    J Pharmacol; 1983; 14 Suppl 2():169-75. PubMed ID: 6138466
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 5.